202 related articles for article (PubMed ID: 18562100)
1. DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients.
Pae CU; Drago A; Kim JJ; Patkar AA; Jun TY; Lee C; Mandelli L; De Ronchi D; Paik IH; Serretti A
Neurosci Lett; 2008 Aug; 440(2):150-4. PubMed ID: 18562100
[TBL] [Abstract][Full Text] [Related]
2. Dysbindin gene variants are associated with bipolar I disorder in a Korean population.
Joo EJ; Lee KY; Jeong SH; Chang JS; Ahn YM; Koo YJ; Kim YS
Neurosci Lett; 2007 May; 418(3):272-5. PubMed ID: 17433541
[TBL] [Abstract][Full Text] [Related]
3. A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis.
Corvin A; Donohoe G; Nangle JM; Schwaiger S; Morris D; Gill M
Neurosci Lett; 2008 Jan; 431(2):146-9. PubMed ID: 18162312
[TBL] [Abstract][Full Text] [Related]
4. The dysbindin gene (DTNBP1) and schizophrenia: no support for an association in the Korean population.
Joo EJ; Lee KY; Jeong SH; Ahn YM; Koo YJ; Kim YS
Neurosci Lett; 2006 Oct; 407(2):101-6. PubMed ID: 16959423
[TBL] [Abstract][Full Text] [Related]
5. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).
Williams NM; Preece A; Morris DW; Spurlock G; Bray NJ; Stephens M; Norton N; Williams H; Clement M; Dwyer S; Curran C; Wilkinson J; Moskvina V; Waddington JL; Gill M; Corvin AP; Zammit S; Kirov G; Owen MJ; O'Donovan MC
Arch Gen Psychiatry; 2004 Apr; 61(4):336-44. PubMed ID: 15066891
[TBL] [Abstract][Full Text] [Related]
6. The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis.
Kishimoto M; Ujike H; Motohashi Y; Tanaka Y; Okahisa Y; Kotaka T; Harano M; Inada T; Yamada M; Komiyama T; Hori T; Sekine Y; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
Biol Psychiatry; 2008 Jan; 63(2):191-6. PubMed ID: 17555717
[TBL] [Abstract][Full Text] [Related]
7. No influence of DTNBP1 polymorphisms on the response to aripiprazole.
Pae CU; Chiesa A; Mandelli L; Serretti A
Neuropsychobiology; 2010; 62(4):245-9. PubMed ID: 20829635
[TBL] [Abstract][Full Text] [Related]
8. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
Molero P; Ortuño F; Zalacain M; Patiño-García A
Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
[TBL] [Abstract][Full Text] [Related]
9. Malic enzyme 2 and susceptibility to psychosis and mania.
Lee BD; Walss-Bass C; Thompson PM; Dassori A; Montero PA; Medina R; Contreras S; Armas R; Ramirez M; Pereira M; Salazar R; Leach RJ; Quezada P; Raventos H; Escamilla MA
Psychiatry Res; 2007 Feb; 150(1):1-11. PubMed ID: 17258816
[TBL] [Abstract][Full Text] [Related]
10. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level.
Stefanis NC; Trikalinos TA; Avramopoulos D; Smyrnis N; Evdokimidis I; Ntzani EE; Ioannidis JP; Stefanis CN
Biol Psychiatry; 2007 Oct; 62(7):784-92. PubMed ID: 17336946
[TBL] [Abstract][Full Text] [Related]
11. Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder.
Kim JJ; Mandelli L; Pae CU; De Ronchi D; Jun TY; Lee C; Paik IH; Patkar AA; Steffens D; Serretti A; Han C
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):375-9. PubMed ID: 17964051
[TBL] [Abstract][Full Text] [Related]
12. Dysbindin and d-amino-acid-oxidase gene polymorphisms associated with positive and negative symptoms in schizophrenia.
Wirgenes KV; Djurovic S; Agartz I; Jonsson EG; Werge T; Melle I; Andreassen OA
Neuropsychobiology; 2009; 60(1):31-6. PubMed ID: 19729970
[TBL] [Abstract][Full Text] [Related]
13. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia.
Fanous AH; van den Oord EJ; Riley BP; Aggen SH; Neale MC; O'Neill FA; Walsh D; Kendler KS
Am J Psychiatry; 2005 Oct; 162(10):1824-32. PubMed ID: 16199828
[TBL] [Abstract][Full Text] [Related]
14. Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample.
Pae CU; Yu HS; Amann D; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH; Patkar AA; Lerer B
J Psychiatr Res; 2008 Jan; 42(1):35-40. PubMed ID: 17097106
[TBL] [Abstract][Full Text] [Related]
15. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families.
van den Oord EJ; Sullivan PF; Jiang Y; Walsh D; O'Neill FA; Kendler KS; Riley BP
Mol Psychiatry; 2003 May; 8(5):499-510. PubMed ID: 12808430
[TBL] [Abstract][Full Text] [Related]
16. A genetic variation in the dysbindin gene (DTNBP1) is associated with memory performance in healthy controls.
Hashimoto R; Noguchi H; Hori H; Nakabayashi T; Suzuki T; Iwata N; Ozaki N; Kosuga A; Tatsumi M; Kamijima K; Harada S; Takeda M; Saitoh O; Kunugi H
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):431-8. PubMed ID: 19353385
[TBL] [Abstract][Full Text] [Related]
17. Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder.
Pae CU; Serretti A; Mandelli L; Yu HS; Patkar AA; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH; Kim JJ
Am J Med Genet B Neuropsychiatr Genet; 2007 Jul; 144B(5):701-3. PubMed ID: 17192893
[TBL] [Abstract][Full Text] [Related]
18. Association analyses of the neuregulin 1 gene with schizophrenia and manic psychosis in a Hispanic population.
Walss-Bass C; Raventos H; Montero AP; Armas R; Dassori A; Contreras S; Liu W; Medina R; Levinson DF; Pereira M; Leach RJ; Almasy L; Escamilla MA
Acta Psychiatr Scand; 2006 Apr; 113(4):314-21. PubMed ID: 16638076
[TBL] [Abstract][Full Text] [Related]
19. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression.
Bray NJ; Preece A; Williams NM; Moskvina V; Buckland PR; Owen MJ; O'Donovan MC
Hum Mol Genet; 2005 Jul; 14(14):1947-54. PubMed ID: 15917270
[TBL] [Abstract][Full Text] [Related]
20. The impact of heat shock protein 70 gene variations on clinical presentation and outcome in schizophrenic inpatients.
Pae CU; Drago A; Kim JJ; Mandelli L; De Ronchi D; Serretti A
Neuropsychobiology; 2009; 59(3):135-41. PubMed ID: 19439993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
